Ligand Pharmaceuticals, Inc. (LGND)
206.40
-2.55
(-1.22%)
USD |
NASDAQ |
Mar 05, 16:00
206.05
-0.35
(-0.17%)
Pre-Market: 20:00
Ligand Pharmaceuticals Cash from Investing (TTM) : -377.32M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Merck & Co., Inc. | -13.74B |
| ADMA Biologics, Inc. | -21.89M |
| Elanco Animal Health, Inc. | -279.00M |
| Ionis Pharmaceuticals, Inc. | -277.78M |